Drugs / ZHCK4
last change Sep 2023 re-read 3 minutes ago

ZHCK4

Developed for
infectious disease
Investigated by
BioScience Laboratories, Inc. · Zaycor Healthcare Corp

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT04703335 Jun → Aug 2023 infectious disease Zaycor Healthcare Corp Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ZHCK4 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04703335 ↗